Gardnerella vaginalis is a type of bacteria that is commonly found in the vaginal flora of some women. While it can be present in the vagina without causing any issues, it is often associated with bacterial vaginosis (BV), a condition that occurs when the natural balance of bacteria in the vagina is disrupted. BV can lead to symptoms such as unusual discharge, a fishy odor, and vaginal irritation, although some women may not experience any symptoms. Gardnerella vaginalis plays a key role in this imbalance because its overgrowth can reduce the number of "good" bacteria like lactobacilli, which normally help maintain a healthy vaginal environment. BV is not considered a sexually transmitted infection (STI), but it is more common in sexually active women. It is usually treated with antibiotics to restore the normal bacterial balance.
--------------------------
Gardnerella vaginalis is a key bacterium associated with bacterial vaginosis (BV), a common vaginal condition characterized by an imbalance in the vaginal microbiome. The presence of G. vaginalis can serve as a biomarker for BV, but its role is complex and nuanced.
G. vaginalis as a Biomarker
Prevalence and Detection
G. vaginalis is found in 95% to 100% of BV cases, making it a highly sensitive biomarker for the condition. However, it's important to note that G. vaginalis can also be present in healthy vaginal microbiomes, albeit in much lower concentrations. Detection methods for G. vaginalis include 16S rRNA gene sequencing and culture-based studies, with some variations in relative levels depending on the specific gene regions targeted.
Specificity Considerations
While G. vaginalis is highly prevalent in BV, its presence alone is not always indicative of the condition. Colonization by G. vaginalis does not necessarily lead to BV, as some women without BV may have low levels of the bacterium. This suggests that the abundance and potentially the specific strains of G. vaginalis may be more relevant as biomarkers than mere presence.
Associated Metabolites
GHB Production
Recent research has identified γ-hydroxybutyrate (GHB) as a highly specific biomarker associated with G. vaginalis. Studies have demonstrated that G. vaginalis is likely the primary source of GHB detected in vivo, with the bacterium possessing a putative GHB dehydrogenase gene. This metabolite could serve as an indirect biomarker for G. vaginalis presence and activity.
Other Metabolic Markers
In addition to GHB, other metabolites such as 2-hydroxyisovalerate (2HV) have been identified as sensitive and specific biomarkers for BV, with G. vaginalis likely playing a role in their production.
Clinical Significance
Diagnostic Potential
The combination of G. vaginalis detection with specific metabolite markers like GHB and 2HV shows promise for improving BV diagnosis. In one study, the ratio of 2HV to tyrosine achieved an area under the curve of 0.993 in predicting clinical BV.
Epithelial Impact
G. vaginalis has been shown to significantly impact cervico-vaginal epithelial function, including increased cell death and decreased barrier integrity. These effects, not observed with beneficial bacteria like Lactobacillus crispatus, could potentially serve as indirect biomarkers of G. vaginalis activity.
Future Directions
Strain-Specific Biomarkers
Recent taxonomic updates have identified multiple species within the Gardnerella genus, suggesting that strain-specific biomarkers may be necessary for more accurate diagnostics. Future research may focus on identifying biomarkers that can differentiate between more and less virulent strains of Gardnerella.
Multispecies Interactions
Given the complex nature of the vaginal microbiome, future biomarker development may need to consider the interactions between G. vaginalis and other bacterial species, as well as host factors, to improve diagnostic accuracy and predict clinical outcomes.In conclusion, while the presence of G. vaginalis serves as an important biomarker for BV, its interpretation requires consideration of abundance, associated metabolites, and the overall vaginal microbiome context. Ongoing research continues to refine our understanding of G. vaginalis as a biomarker and its role in vaginal health and disease.
Gardenerella vaginalis
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.